ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO0813

Analysis of Costs, Quality of Life, and Nutritional Status Between Patients with Two Different Models of Hemodialysis in Mexico: Chronic vs. Intermittent Hemodialysis

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Lima-Lucero, Jesus Daniel, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
  • Cordoba Hurtado, Angela Maria, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
  • Valdez-Ortiz, Rafael, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
  • Perez-Navarro, L. Monserrat, Hospital General de Mexico Dr Eduardo Liceaga, Ciudad de Mexico, Ciudad de Mexico, Mexico
Background

In Mexico, access to conventional chronic hemodialysis (cHD) programs (two or three hemodialysis sessions a week) is only possible in a few patients. In contrast, patients without social security usually are undergo intermittent hemodialysis (IHD) sessions, this is weekly, biweekly or even monthly sessions when the signs and symptoms of dialysis urgency are present. We aim was to compare the costs, quality of life and nutritional status among two different model hemodialysis: cHD versus IHD.

Methods

Pilot cost study. Costs generated by HD sessions and indirect costs reported by the patient are evaluated to obtain out-of-pocket expenses (medicines, transportation, food, medical supplies). Nutritional status was evaluated through the malnutrition and inflammation score (MIS) and quality of life through the SF-36 questionnaire.

Results

Twenty patients were analyzed 55% male, with a mean age of 40.5 ± 14.9 years, the main cause of CKD was unknown (60%), and the main comorbidity was HTA (95%). Eleven in cHD and nine in IHD. In Fig 1, shown biochemical characteristics, MIS, grip strength, and costs are presented by study group. The quality of life analysis showed worse scores in symptoms; effects of kidney disease, morbidity of kidney disease; physical component; and mental component (p ≦ 0.05).

Conclusion

Although not statistically significant differences were identified in out-of-pocket spending between models, patients with IHD presented worse score MIS and quality of life. A health policy is necessary that allows universal access to renal replacement therapies in Mexico.